SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

7 Jun 2021 16:37

RNS Number : 0784B
Caledonia Investments PLC
07 June 2021
Β 

Caledonia Investments plc

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

Β 

Pursuant to the requirements of the Market Abuse Regulation, Caledonia Investments plc ("Caledonia" or the "Company") announces that on 4 June 2021 the following nil-cost options over ordinary 5p shares in Caledonia were granted to executive directors under the Caledonia Investments 2020 Performance Share Scheme (the "Performance Share Scheme") and in respect of compulsory deferral of bonus under the Caledonia Investments 2020 Deferred Bonus Plan (the "Deferred Bonus Plan"). The Company's share price used to determine the number of Performance Share Scheme awards and Deferred Bonus Plan awards was 3102.5p.

Β 

Executive Director

No. of shares over which Performance Share Scheme nil-cost options granted

No. of shares subject to Deferred Bonus Plan

J M B Cayzer-Colvin

16,873

4,431

T J Livett

18,868

4,956

W P Wyatt

26,108

6,092

Β 

Subject to the rules of the Performance Share Scheme, nil-cost options are exercisable between three and ten years after the date of grant. Subject to the rules of the Deferred Bonus Plan, deferred share awards vest after a three year retention period.

Β 

The total number of awards held by the above-named executive directors of Caledonia under the Company's performance share schemes and deferred bonus plans following these nil-cost option grants are as follows:

Β 

Executive Director

Total no. of shares held under option under performance share scheme

Total deferred bonus plan share awards

J M B Cayzer-Colvin

92,872

10,050

T J Livett

60,039

4,956

W P Wyatt

147,326

13,652

Β 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

Β 

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Tel: + 44 20 7802 8080

Β 

7 June 2021

Β 

APPENDIX

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

James Michael Beale Cayzer-Colvin

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Executive Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil-cost options over ordinary 5p shares under (1) the Caledonia Investments 2020 Performance Share Scheme ("PSS") and (2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Description

Price(s)

Β 

Volume(s)

Grant of PSS award

Β 

Β£0.00

Β 

16,873

Grant of DBP award

Β 

Β£0.00

4,431

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

21,304

Β 

Nil

e)

Β 

Date of the transaction

Β 

4 June 2021

f)

Place of the transaction

Outside a trading venue

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Timothy James Livett

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Director/Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil-cost options over ordinary 5p shares under (1) the Caledonia Investments 2020 Performance Share Scheme ("PSS") and (2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Grant of PSS awards

Β 

Β 

Β 

Β 

Description

Price(s)

Β 

Volume(s)

Grant of PSS award

Β 

Β£0.00

Β 

18,868

Grant of DBP award

Β 

Β£0.00

4,956

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

23,824

Β 

Nil

e)

Β 

Date of the transaction

Β 

4 June 2021

f)

Place of the transaction

Outside a trading venue

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

William Penfold Wyatt

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Director/Chief Executive

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil-cost options over ordinary 5p shares under (1) the Caledonia Investments 2020 Performance Share Scheme ("PSS") and (2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Β 

Description

Price(s)

Β 

Volume(s)

Grant of PSS award

Β 

Β£0.00

Β 

26,108

Grant of DBP award

Β 

Β£0.00

6,092

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

32,200

Β 

Nil

Β 

e)

Β 

Date of the transaction

Β 

4 June 2021

f)

Place of the transaction

Outside a trading venue

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBUGDLLXGDGBR
Date   Source Headline
11th Oct 20125:06 pmRNSHolding(s) in Company
10th Oct 20125:11 pmRNSTransaction in Own Shares
8th Oct 20125:04 pmRNSForm 8.3 - A.G. Barr p.l.c.
5th Oct 20125:37 pmRNSForm 8.3 - A.G. Barr p.l.c.
5th Oct 201211:10 amRNSNet Asset Value(s)
3rd Oct 20128:59 amRNSForm 8.3 - A.G. Barr p.l.c.
1st Oct 20128:55 amRNSForm 8.3 - A.G. Barr p.l.c.
1st Oct 20127:00 amRNSPortfolio Acquisition
28th Sep 20125:12 pmRNSTransaction in Own Shares
28th Sep 20125:10 pmRNSTotal Voting Rights
28th Sep 20128:32 amRNSForm 8.3 - A.G. Barr
20th Sep 20125:36 pmRNSTransaction in Own Shares
19th Sep 20125:08 pmRNSTransaction in Own Shares
19th Sep 201210:40 amRNSForm 8.3 - A.G. Barr p.l.c.
11th Sep 20124:57 pmRNSTransaction in Own Shares
7th Sep 20128:54 amRNSNet Asset Value(s)
6th Sep 20129:20 amRNSForm 8.3 - A.G. Barr p.l.c.
4th Sep 20124:19 pmRNSHolding(s) in Company
31st Aug 20125:13 pmRNSTotal Voting Rights
31st Aug 20125:07 pmRNSTransaction in Own Shares
30th Aug 20125:24 pmRNSTransaction in Own Shares
17th Aug 20125:28 pmRNSDirector Declaration
17th Aug 20125:08 pmRNSForm 8.3 - Melrose Resources plc
10th Aug 20125:04 pmRNSTransaction in Own Shares
9th Aug 20124:50 pmRNSTransaction in Own Shares
6th Aug 20122:21 pmRNSNet Asset Value(s)
31st Jul 20125:19 pmRNSTotal Voting Rights
31st Jul 20123:42 pmRNSDirector/PDMR Shareholding
27th Jul 20125:23 pmRNSHolding(s) in Company
26th Jul 20125:12 pmRNSTransaction in Own Shares
25th Jul 201212:47 pmRNSResult of AGM
23rd Jul 20123:30 pmRNSDirector/PDMR Shareholding
19th Jul 20123:34 pmRNSDirector/PDMR Shareholding
12th Jul 20125:01 pmRNSTransaction in Own Shares
9th Jul 20124:57 pmRNSTransaction in Own Shares
6th Jul 20124:55 pmRNSTransaction in Own Shares
6th Jul 20123:10 pmRNSDirector/PDMR Shareholding
6th Jul 201210:49 amRNSInterim Management Statement
6th Jul 201210:06 amRNSNet Asset Value(s)
4th Jul 20123:28 pmRNSDirector/PDMR Shareholding
3rd Jul 20126:05 pmRNSHolding(s) in Company
3rd Jul 20125:07 pmRNSTransaction in Own Shares
2nd Jul 20122:33 pmRNSBlocklisting Interim Review
29th Jun 20125:23 pmRNSTotal Voting Rights
22nd Jun 20125:03 pmRNSHolding(s) in Company
21st Jun 20125:22 pmRNSTransaction in Own Shares
19th Jun 201210:05 amRNSAnnual Financial Report
18th Jun 20125:51 pmRNSTransaction in Own Shares
15th Jun 20124:35 pmRNSPrice Monitoring Extension
15th Jun 20122:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.